Skip to content

Seminar Title

 

Synergy Satellite: Targeted drugs – scattered goals (sponsored by a grant from Novartis)

Affiliation

German Cancer Research Center & University Hospital Heidelberg

Country

Germany

1. Current Status, Position

  • Head of Division, CCU Pediatric Oncology, DKFZ Heidelberg;
  • Head of Division, Pediatric Brain Tumors, University Hospital Heidelberg.

2. Education

  • Training in Pediatrics, Pediatric Oncology and Neonatal Medicine at University of Göttingen Medical School;
  • Postdoctoral Fellow in Molecular Biology of Histone Family Variants in Cancer at University of Göttingen;
  • W3 joined professorship at DKFZ/University Hospital Heidelberg and Head of Division CCU Pediatric Oncology since 2005.

3. Research Area

  • Clinical Specialization in Pediatric Neurooncology;
  • Interest in Personalized Pediatric Oncology, novel targeted treatment approaches, clinical translation of novel targets based on mechanism of action;
  • Evaluation of individual members of histone deacetylase family as selective drug targets and their mechanism of action.

Conflict of interest: Consultant for Astra Zeneca and Novartis and Research Grant Recipient from Bayer Healthcare.

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.